Literature DB >> 19734625

BACE1 is a newly discovered protein secreted by the pancreas which cleaves enteropeptidase in vitro.

Albrecht Hoffmeister1, Gunther Dietz, Ulrike Zeitschel, Joachim Mössner, Steffen Rossner, Tobias Stahl.   

Abstract

CONTEXT: Activity of beta-site APP-cleaving enzyme1 (BACE1) is required for the generation of beta-amyloid peptides, the principal constituents of plaques in the brains of patients with Alzheimer's disease. Strong BACE1 expression has also been described in pancreatic tissue.
OBJECTIVE: The aim of the present study was to reveal the cell type-specific expression of BACE1 in the pancreas and to identify a substrate for BACE1 in this organ.
METHODS: RT-PCR of microdissected rat pancreatic tissue was carried out in order to analyze BACE1 expression within pancreatic acini. Pancreatic juice was examined by western blot analysis and by an enzymatic activity assay in order to reveal the presence of secreted BACE1. Database analysis suggested enteropeptidase as a putative substrate for BACE1 in pancreatic juice. In vitro digestion of enteropeptidase by BACE1 was performed to demonstrate this cleavage.
RESULTS: We demonstrate the expression of BACE1 in the islets of Langerhans and at the apical pole of pancreatic acinar cells. Recombinant BACE1 cleaves enteropeptidase in vitro. Furthermore, some results suggested the presence of BACE1 enzymatic activity in pancreatic juice and pancreatic tissue. DISCUSSION: We hypothesize that enteropeptidase is a BACE1 substrate in vivo. If so, BACE1 could protect the pancreas from premature trypsinogen activation due to the occasionally occurring reflux of enteropeptidase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734625

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  8 in total

1.  Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study.

Authors:  Boris Decourt; Aaron Walker; Amanda Gonzales; Michael Malek-Ahmadi; Carolyn Liesback; Kathryn J Davis; Christine M Belden; Sandra A Jacobson; Marwan N Sabbagh
Journal:  Platelets       Date:  2012-07-09       Impact factor: 3.862

2.  Development of a specific ELISA to measure BACE1 levels in human tissues.

Authors:  Amanda Gonzales; Boris Decourt; Aaron Walker; Rachel Condjella; Hikmet Nural; Marwan N Sabbagh
Journal:  J Neurosci Methods       Date:  2011-08-25       Impact factor: 2.390

Review 3.  Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships?

Authors:  Andrew J Beel; Masayoshi Sakakura; Paul J Barrett; Charles R Sanders
Journal:  Biochim Biophys Acta       Date:  2010-03-18

4.  Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation.

Authors:  Demian Obregon; Huayan Hou; Juan Deng; Brian Giunta; Jun Tian; Donna Darlington; Md Shahaduzzaman; Yuyuan Zhu; Takashi Mori; Mark P Mattson; Jun Tan
Journal:  Nat Commun       Date:  2012-04-10       Impact factor: 14.919

Review 5.  β-Secretase: its biology as a therapeutic target in diseases.

Authors:  Haibo Wang; Rena Li; Yong Shen
Journal:  Trends Pharmacol Sci       Date:  2013-02-27       Impact factor: 14.819

Review 6.  Membrane-anchored serine proteases in health and disease.

Authors:  Toni M Antalis; Thomas H Bugge; Qingyu Wu
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

7.  The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer's Disease and Beyond.

Authors:  Bastian Dislich; Stefan F Lichtenthaler
Journal:  Front Physiol       Date:  2012-02-17       Impact factor: 4.566

8.  Loss of Bace1 in mice does not alter the severity of caerulein induced pancreatitis.

Authors:  Mario Heindl; Jan Tuennemann; Ines Sommerer; Joachim Mössner; Albrecht Hoffmeister
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.